Additional Analyst Calls Briefing for Friday, October 21, 2022

Investing

Published: October 21, 2022 8:08 am

This report was sent to Briefing.com subscribers earlier today.

Upgrades:

AT&T (T) upgraded to Buy from Hold at Truist; tgt $21
GFL Environmental (GFL) upgraded to Buy from Neutral at BofA Securities; tgt lowered to $32.50.
Juniper Networks (JNPR) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $37
Moderna (MRNA) upgraded to Mkt Perform from Underperform at SVB Leerink; tgt lowered to $101
SAP SE (SAP) upgraded to Overweight from Neutral at JP Morgan

CVB Financial (CVBF) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $32
Equifax (EFX) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $158
First Internet Bancorp (INBK) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $30
Immunic (IMUX) downgraded to Mkt Perform from Outperform at SVB Leerink; tgt $5
Ovintiv (OVV) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $57
Robert Half (RHI) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $76
Snap (SNAP) downgraded to Mkt Perform from Outperform at Bernstein; tgt lowered to $9
Snap (SNAP) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $11
Snap (SNAP) downgraded to Neutral from Buy at MKM Partners; tgt lowered to $10
SVB Financial Group (SIVB) downgraded to Neutral from Buy at Janney
SVB Financial Group (SIVB) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $265
Under Armour (UAA) downgraded to Market Perform from Outperform at Telsey Advisory Group; tgt lowered to $8
Zymeworks (ZYME) downgraded to Mkt Perform from Outperform at SVB Leerink; tgt $8

CCC Intelligent Solutions (CCCS) initiated with an Equal Weight at Barclays; tgt $10
Cerberus Cyber Sentinel (CISO) initiated with an Overweight at Cantor Fitzgerald; tgt $5
Ormat Tech (ORA) initiated with a Neutral at Citigroup; tgt $91
Pacira BioSciences (PCRX) assumed with a Buy at Jefferies; tgt $66
Palo Alto Networks (PANW) initiated with an Overweight at Cantor Fitzgerald; tgt $220
Phathom Pharmaceuticals (PHAT) initiated with a Buy at Jefferies; tgt $16
Revolution Medicines (RVMD) initiated with an Outperform at Oppenheimer; tgt $30
RVL Pharmaceuticals (RVLP) assumed with a Hold at Jefferies; tgt $2.50
scPharmaceuticals (SCPH) assumed with a Buy at Jefferies; tgt $14
Sol-Gel (SLGL) assumed with a Hold at Jefferies; tgt $5.50
Tenable (TENB) resumed with a Hold at Berenberg; tgt $32
Teva Pharma (TEVA) assumed with a Buy at Jefferies; tgt $10
Univar Solutions (UNVR) initiated with an Outperform at Credit Suisse; tgt $31
Viatris (VTRS) assumed with a Hold at Jefferies; tgt $11
Xeris Biopharma (XERS) initiated with a Buy at Jefferies; tgt $4
Zscaler (ZS) initiated with a Neutral at Cantor Fitzgerald; tgt $160

Read more: Investing, Analyst Downgrades, Analyst Upgrades

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.